HC Wainwright & Co. Reiterates Buy on Curis, Maintains $17 Price Target

HC Wainwright & Co. analyst Sara Nik has reiterated a 'Buy' rating on Curis (NASDAQ: CRIS) and maintained a price target of $17 for the stock. No additional financial figures or strategic changes were mentioned in the article.